Mireille Hunziker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mireille Hunziker has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Anja Makhdoomi
Cantonal Hospital Baselland, University Center of Internal Medicine, Rheinstrasse 26, 4410 Liestal, Switzerland
1 shared publication - Anne Barbara Leuppi-Taegtmeyer
Department of Patient Safety, Medical Directorate, University Hospital Basel, Basel, Switzerland.
1 shared publication - Giorgia Lüthi-Corridori
University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland
1 shared publication - Joerg Daniel Leuppi
University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland
1 shared publication - Jürgen Muser
Central Laboratories, Cantonal Hospital Baselland, Rheinstrasse 26, 4410 Liestal, Switzerland
1 shared publication - Maria Boesing
University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland
1 shared publication
Latest Publications
- Open Access
- 25 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5520
Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study
(1) Background: SARS-COV2 infection has a clinical spectrum ranging from asymptomatic infection to COVID-19 with acute respiratory distress syndrome (ARDS). Although vitamin D deficiency is often found in patients with ARDS, its role in COVID-19 is not clear. The aim of this study was to explore a possible association between serum 25-hydroxyvitamin D levels and the severity of COVID-19 in hospitalised patients. (2) Methods: In this retrospective observational study, we analysed data from 763 patients hospitalised for COVID-19 in 2020 and 2021. Patients were included in the study if serum 25-hydroxyvitamin D was assessed 30 days before or after hospital admission. Vitamin D deficiency was defined as p = 0.829). (4) Conclusion: No association was found between serum 25-hydroxyvitamin D levels and COVID-19 severity in this large observational study conducted over 2 years of the pandemic.
- 25 August 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5520
Open AccessIs Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study
(1) Background: SARS-COV2 infection has a clinical spectrum ranging from asymptomatic infection to COVID-19 with acute respiratory distress syndrome (ARDS). Although vitamin D deficiency is often found in patients with ARDS, its role in COVID-19 is not clear. The aim of this study was to explore a possible association between serum 25-hydroxyvitamin D levels and the severity of COVID-19 in hospitalised patients. (2) Methods: In this retrospective observational study, we analysed data from 763 patients hospitalised for COVID-19 in 2020 and 2021. Patients were included in the study if serum 25-hydroxyvitamin D was assessed 30 days before or after hospital admission. Vitamin D deficiency was defined as p = 0.829). (4) Conclusion: No association was found between serum 25-hydroxyvitamin D levels and COVID-19 severity in this large observational study conducted over 2 years of the pandemic.